Juanjuan Zhao

127 Dongming Road
Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Construction and characterization of chimeric FcγR T cells for universal T cell therapy.

Construction and characterization of chimeric FcγR T cells for universal T cell therapy.

Journal: Experimental hematology & oncology
Published: July 21, 2024

Intrathecal tocilizumab for immune-mediated central nervous system complication after haploidentical hematopoietic stem cell transplantation in children: Two case reports.

Intrathecal tocilizumab for immune-mediated central nervous system complication after haploidentical hematopoietic stem cell transplantation in children: Two case reports.

Journal: Heliyon
Published: May 22, 2024

Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting.

Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting.

Journal: Journal of hematology & oncology
Published: June 20, 2023

CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting.

CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting.

Journal: Journal of hematology & oncology
Published: June 10, 2023

Effect of arsenic trioxide on the Tregs ratio and the levels of IFN-γ, IL-4, IL-17 and TGF-β1 in the peripheral blood of severe aplastic anemia patients.

Effect of arsenic trioxide on the Tregs ratio and the levels of IFN-γ, IL-4, IL-17 and TGF-β1 in the peripheral blood of severe aplastic anemia patients.

Journal: Medicine
Published: June 27, 2020

Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia.

Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia.

Journal: Biomarker research
Published: October 23, 2019

Recent advances on blinatumomab for acute lymphoblastic leukemia.

Recent advances on blinatumomab for acute lymphoblastic leukemia.

Journal: Experimental hematology & oncology
Published: October 07, 2019

Recent updates on CAR T clinical trials for multiple myeloma.

Recent updates on CAR T clinical trials for multiple myeloma.

Journal: Molecular cancer
Published: August 18, 2019

Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia.

Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia.

Journal: Biomarker research
Published: July 22, 2019

Frontline therapies for untreated chronic lymphoid leukemia.

Frontline therapies for untreated chronic lymphoid leukemia.

Journal: Experimental hematology & oncology
Published: June 15, 2019

Engineering switchable and programmable universal CARs for CAR T therapy.

Engineering switchable and programmable universal CARs for CAR T therapy.

Journal: Journal of hematology & oncology
Published: May 08, 2019

Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia.

Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia.

Journal: Journal of hematology & oncology
Published: January 12, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026